Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
clinical trials
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
bristol-myers squibb
cancer
intercept pharmaceuticals
new york blog main
new york top stories
nonalcoholic steatohepatitis
obeticholic acid
san diego blog main
san diego top stories
4d molecular therapeutics
abbvie
acne
agenus
allergan
astrazeneca
auris health
avexis
bayer
biomx
bladder cancer
boulder/denver blog main
boulder/denver top stories
broad institute of mit and harvard
cancer drugs
cancer immunotherapy
cancer vaccines
car-t immunotherapy
celgene
centers for medicare and medicaid services
clinical data
colorectal cancer
What
disease
3
×
known
3
×
approved
drug
fatty
liver
nash
bio
cancer
cancer’s
companies
data
digital
epidemic
fda
frenzied
frontiers
growing
horizon
intercept
ipo
led
maps
marketed
medicine
medicines
merck
new
news
nonalcoholic
parlance
pharmaceutical
play
proteins
race
reach
research
revealed
revolution
role
Language
unset
Current search:
known
×
disease
×
" boston top stories "
×
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
